Synapse - Elsevier Ltd

Elsevier Ltd

SHERPA: Unknown

People

Tallman
Abdel-Wahab
Levine
Berman
Stein
Derkach
Devlin
Jhanwar
O'Reilly
Papaemmanuil

Groups

Department of Medicine (80)
Hematologic Malignancies, Division of (76)
Center for Hematologic Malignancies (69)
Adult Leukemia (52)
GSK Faculty (32)
Epidemiology and Biostatistics (26)
Tow Center for Developmental Oncology (TCDO) (23)
Sloan Kettering Institute Faculty (19)
Biostatistics Service (18)
Executive Committee, Center for Hematologic Malignancies (18)

Search Within

Results (128)

Export to EndNote / Excel

A phase I trial of targeted immunotherapy with daratumumab following myeloablative total body irradiation (TBI)-based conditioning and allogeneic hematopoietic cell transplantaton in children, adolescents and young adults with high-risk T-cell acute lymphoblastic leukemia and lymphoma (T- ALL/T-LLy) (ALLO-T-DART) (IND 159396): A PTCTC facilitated study

Meeting Abstract

Quigg, T.; Flower, A.; Teachey, D.; Lim, M.; Chu, Y.; Harrison, L.; Morris, E.; Gardenswartz, A.; Hochberg, J.; Ozkaynak, M.; more...
Leukemia Research (2022)

Fulltext@MSK | Save

Burkitt lymphoma and high-grade B-cell lymphphoma with 11q abberrations share a transcriptional profile resembling a subpopulation of early dark zone cells

Meeting Abstract

Di Stefano, G.; Chteinberg, E.; Loeffler-Wirth, H.; Hillebrecht, S.; Wagener, R.; Abramov, D.; Burkhardt, B.; Louissant, A.; Horn, H.; Mottok, A.; more...
Leukemia Research (2022)

Fulltext@MSK | Save

Real-world analysis of the safety/tolerability of gilteritinib in combination with mold-active azole prophylaxis

Research Letter

King, A. C.; Derkach, A.; Weis, T. M.; Stump, S. E.; Ciervo, J. R.; Ranaghan, C. P.; Stein, E. S.
Leukemia Research (2022)

Fulltext@MSK | Save

Dermatologic adverse events associated with IDH inhibitors ivosidenib and enasidenib for the treatment of acute myeloid leukemia

Journal Article

Parisi, R.; Cowen, E. A.; Stoll, J. R.; Zhu, H.; Dusza, S.; Pulitzer, M. P.; Stein, E. M.; Markova, A.
Leukemia Research (2022)

Fulltext@MSK | Save

Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profiling

Journal Article

Ganzel, C.; Sun, Z.; Baslan, T.; Zhang, Y.; Gönen, M.; Abdel-Wahab, O. I.; Racevskis, J.; Garrett-Bakelman, F.; Lowe, S. W.; Fernandez, H. F.; more...
Leukemia Research (2022)

Fulltext@MSK | Save

Efficacy of FLT3 and IDH1/2 inhibitors in patients with acute myeloid leukemia previously treated with venetoclax

Journal Article

Bewersdorf, J. P.; Shallis, R. M.; Derkach, A.; Goldberg, A. D.; Stein, A.; Stein, E. M.; Marcucci, G.; Zeidan, A. M.; Shimony, S.; DeAngelo, D. J.; more...
Leukemia Research (2022)

Fulltext@MSK | Save

Quantitative chest computed tomography combined with plasma cytokines predict outcomes in COVID-19 patients

Journal Article

Carbonell, G.; Del Valle, D. M.; Gonzalez-Kozlova, E.; Marinelli, B.; Klein, E.; El Homsi, M.; Stocker, D.; Chung, M.; Bernheim, A.; Simons, N. W.; more...
Heliyon (2022)

Fulltext@MSK | Save

De Novo myelodysplastic syndromes in patients 20–50 years old are enriched for adverse risk features

Journal Article

Epstein-Peterson, Z. D.; Spitzer, B.; Derkach, A.; Arango, J. E.; McCarter, J. G. W.; Medina-Martínez, J. S.; McGovern, E.; Farnoud, N. R.; Levine, R. L.; Tallman, M. S.
Leukemia Research (2022)

Fulltext@MSK | Save

Tipifarnib as maintenance therapy did not improve disease-free survival in patients with acute myelogenous leukemia at high risk of relapse: Results of the phase III randomized E2902 trial